Swarmer, Inc Common Stock (SWMR) has had the highest return between February 28, 2026 and March 30, 2026 by a small-cap US stock, returning 179%.
| ASSET | DATE | % RETURN |
|---|---|---|
Swarmer, Inc Common Stock (SWMR) | 2/28/2026 - 3/30/2026 | 178.96% |
Roma Green Finance Limited Ordinary Shares (ROMA) | 2/28/2026 - 3/30/2026 | 157.14% |
AleAnna, Inc Class A Common Stock (ANNA) | 2/28/2026 - 3/30/2026 | 155.56% |
Polaryx Therapeutics, Inc Common Stock (PLYX) | 2/28/2026 - 3/30/2026 | 148.09% |
Alto Ingredients (ALTO) | 2/28/2026 - 3/30/2026 | 100.44% |
Satellogic V (SATL) | 2/28/2026 - 3/30/2026 | 97.67% |
One and One Green Technologies Inc Class A Ordinary Shares (YDDL) | 2/28/2026 - 3/30/2026 | 95.34% |
Advantage Solutions (ADV) | 2/28/2026 - 3/30/2026 | 91.54% |
Akso Health Group ADR (AHG) | 2/28/2026 - 3/30/2026 | 69.78% |
Lightwave Logic (LWLG) | 2/28/2026 - 3/30/2026 | 64.06% |
Braiin Limited Common Stock (BRAI) | 2/28/2026 - 3/30/2026 | 61.77% |
Uniqure (QURE) | 2/28/2026 - 3/30/2026 | 60.72% |
Paysign (PAYS) | 2/28/2026 - 3/30/2026 | 60.57% |
Ziff Davis (ZD) | 2/28/2026 - 3/30/2026 | 58.75% |
Falcon's Beyond Global, Inc Class A Common Stock (FBYD) | 2/28/2026 - 3/30/2026 | 57.1% |
Shattuck Labs (STTK) | 2/28/2026 - 3/30/2026 | 56.36% |
Nautilus Biotechnology (NAUT) | 2/28/2026 - 3/30/2026 | 50.65% |
Ovid Therapeutics (OVID) | 2/28/2026 - 3/30/2026 | 46.5% |
BitVentures (BVC) | 2/28/2026 - 3/30/2026 | 45.66% |
Spire Global (SPIR) | 2/28/2026 - 3/30/2026 | 43.72% |
Relmada Therapeutics (RLMD) | 2/28/2026 - 3/30/2026 | 41.94% |
Verb Technology (VERB) | 2/28/2026 - 3/30/2026 | 41.58% |
Gevo (GEVO) | 2/28/2026 - 3/30/2026 | 40% |
Innventure (INV) | 2/28/2026 - 3/30/2026 | 38.5% |
P3 Health Partners (PIII) | 2/28/2026 - 3/30/2026 | 38.03% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
